Simon Völkl

13PUBLICATIONS
137CO-AUTHORS
Liquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AllergyMusic technology and recording
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 15, 2026
FAS-controlled T cells drive lymphoproliferation through glycolysis without effector differentiation.

|Feb 05, 2026
Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases.

Marco Becilli, Markus Metzler, Claudia Bracaglia

|Jan 07, 2026
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial.

Fabian Müller, Melanie Hagen, Andreas Wirsching

|Jun 12, 2025
Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphoma.

Fabian Müller, Nora Rebecca Schwingen, Melanie Hagen

|May 13, 2025
Large B-cell lymphoma imprints a dysfunctional immune phenotype that persists years after treatment.

Richard J Pelzl, Giulia Benintende, Franziska Gsottberger

|May 07, 2025
Augmented CD47 expression impairs alloreactive T-cell clearance after allo-HCT.

Cindy Flamann, Haroon Shaikh, Carina Matos

Pageof 3

Frequent Collaborators

7 joint publications

Andreas Mackensen

5 joint publications

Fabian Müller

2 joint publications

Sascha Kretschmann

2 joint publications

Sareetha Kailayangiri